Falco Holdings Co. Ltd. reported a net profit of ¥1.41 billion for the nine months ended December 31, 2024, edging out the ¥1.37 billion recorded during the same period last year. The marginal increase in the bottom line was supported by steady revenue and improved operational efficiency, according to the company’s latest financial filing.
The Kyoto-based healthcare services firm saw its group revenue reach ¥32.78 billion, a slight increase from the ¥32.73 billion reported in the previous fiscal year. While the top-line growth was modest, the company demonstrated stronger performance in its core profitability metrics. Operating profit climbed to ¥1.75 billion, up from ¥1.66 billion, while pretax profit reached ¥1.91 billion.
Growth in Shareholder Returns
Earnings per share (EPS) showed a notable improvement during the period. The company reported basic earnings per share of ¥140.51, compared to ¥128.82 in the prior year. Diluted earnings per share followed a similar trajectory, rising to ¥139.96 from ¥128.29. This increase reflects the firm's ability to extract more value for shareholders despite a competitive market environment.
Key performance indicators for the nine-month period include:
- Total group revenue of ¥32.78 billion.
- Operating profit growth of approximately 5.4% year-over-year.
- A net profit margin maintained at roughly 4.3%.
The results were prepared in accordance with Japanese accounting standards. Falco Holdings continues to maintain a stable financial position as it enters the final quarter of its fiscal year, balancing consistent revenue streams with controlled operating costs.
Comments (0)
No comments yet. Be the first!